Ellipse Technologies

Aliso Viejo, United States Founded: 2005 • Age: 21 yrs Acquired By NuVasive
Remote-controlled implants for spinal and orthopedic applications are provided.

About Ellipse Technologies

Ellipse Technologies is a Healthcare company based in Aliso Viejo (United States) founded in 2005, and was acquired by NuVasive in January 2016. Remote-controlled implants for spinal and orthopedic applications are provided. Ellipse Technologies has raised $32.41 million across 4 funding rounds from investors including NuVasive, HBM Healthcare Investments and Esfin Gestion. The company has 101 employees. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is ELLIPSE TECHNOLOGIES, INC. Its competitors include Nevro, ATEC Spine and Vertos Medical; 2 of its 3 listed competitors have raised funding.

Company details

Ellipse Technologies was founded in 2005 and is headquartered in Aliso Viejo, United States. Focus is placed on the medical device sector, where remote-controlled implants for spinal and orthopedic uses are developed. Two systems have been commercialized: the Magec-Eos bracing and distraction device for early-onset scoliosis, and the Precice limb-lengthening system for discrepancies in limb lengths. Operations center on orthopedic surgery applications.

  • Headquarters Aliso Viejo, United States
  • Employees 101
  • Stage Acquired
  • Sectors
    Healthcare
  • Website ellipse-tech.com
  • Social LinkedIn X
  • Acquired by NuVasive (Jan 2016)
  • Legal Name Ellipse Technologies, Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $32.41M (USD)

    in 4 rounds

  • Latest Funding Round
    $10M (USD), Series C

    Jun 2015

  • Investors
    NuVasive

    & 4 more

  • Employee Count
    101
  • Acquired by
    NuVasive

    (Jan 2016)

Funding Insights of Ellipse Technologies

Ellipse Technologies has successfully raised a total of $32.41M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $32.41M
  • Total Rounds 4
  • Last Round Series C — $10M
  • First Round $3M

    (Jan 2010)

  • Investors Count 4

All 4 funding rounds of Ellipse Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2015$10MSeries C––
–
Aug 2011$17.6MSeries C–Wexford Capital, Esfin Gestion
–
Oct 2010$1.81MSeries A––
–
Jan 2010$3MSeries A––
–
Valuation history

5 investors in total: 5 institutional.

Investors in Ellipse Technologies

Ellipse Technologies has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include NuVasive, HBM Healthcare Investments and Esfin Gestion.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Wexford Capital is engaged in alternative investment solutions.
1994wexford.comWest Palm Beach, United States
Private equity investment firm focused on energy sector
1983esfingestion.frParis, France
Life sciences focused VC firm funding companies in the US and Europe
2001hbmhealthcare.comZug, Switzerland
Healthtech startups are funded by BioStar Capital's venture capital efforts.
biostarcapital.comCharlevoix, United States
Smart surgical devices for spinal surgery are developed.
1997nuvasive.comSan Diego, United States
Premium access

Investor details for Ellipse Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Ellipse Technologies

4 dated milestones of Ellipse Technologies across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ellipse Technologies is founded.
  2. Funding First funding round of $3.0M.
  3. Funding Latest funding round, Series C, of $10.0M.
  4. Exit Acquired by NuVasive.

Competitors of Ellipse Technologies

Ellipse Technologies has 3 listed competitors in our database, 2 of them funded. They include Nevro, ATEC Spine and Vertos Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nevro.com2006Menlo Park, United States$154.1M1,215
Provider of high-frequency spinal cord stimulation implants
atecspine.com1990San Diego, United States839
Treatment solutions for spine disorders are developed.
vertosmed.com2005Aliso Viejo, United States$177.75M140
Minimally invasive treatments for lumbar spinal stenosis are developed.
Premium access

Detailed competitors of Ellipse Technologies

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Orthopedics

3 companies that operate in the same segment as Ellipse Technologies (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ellipse Technologies

Premium access

Complete news archive for Ellipse Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ellipse Technologies

Ellipse Technologies was founded in 2005 and raised its 1st funding round 5 years after it was founded.

Ellipse Technologies is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.

Ellipse Technologies is a funded company, having raised a total of $32.41M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Jan 2010.

Ellipse Technologies has 101 employees.

Ellipse Technologies was founded in 2005 and is headquartered in Aliso Viejo, United States. Focus is placed on the medical device sector, where remote-controlled implants for spinal and orthopedic uses are developed. Two systems have been commercialized: the Magec-Eos bracing and distraction device for early-onset scoliosis, and the Precice limb-lengthening system for discrepancies in limb lengths. Operations center on orthopedic surgery applications.

Ellipse Technologies's top competitors include Nevro, ATEC Spine and Vertos Medical.

Ellipse Technologies has 5 investors. Key investors include NuVasive, HBM Healthcare Investments, Esfin Gestion, Wexford, and BioStar Capital.

Ellipse Technologies operates through Ellipse Technologies, Inc..

Yes. Ellipse Technologies was acquired by NuVasive in January 2016.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available